BioSpace News Archive

Job Trends

Blue Cross and Blue Shield of Texas Invests More Than $1.6 Million to Help Mitigate Social Conditions that Impact Health

Statewide funding will support community-based initiatives making a difference beyond traditional care settings

July 17, 2019
·
3 min read
Business

Second Quarter 2019 Earnings Release And Conference Call

Torchmark Corporation (NYSE: TMK) will release Second Quarter 2019 earnings after the market closes on Wednesday, July 24 2019.

July 17, 2019
·
1 min read
BioForest

Know Labs Announces Significant Pre-Clinical Progress of UBAND Non-Invasive Continuous Glucose Monitor

Increased accuracy and precision in laboratory test subject measurements have allowed the Company to expedite its focus on an FDA-approved CGM, causing it to curtail plans for its previously announced calorie counter product for the consumer market.

July 17, 2019
·
5 min read
Business

BioCity and Oxford AHSN Partner to Accelerate Life Science Businesses in the Golden Triangle

BioCity, a pioneering life science incubator and business collective, has announced a new strategic partnership with Oxford AHSN.

July 17, 2019
·
4 min read
Policy

Notice to the Media - The Honourable Ginette Petitpas Taylor, Minister of Health, to announce federal funding to address the opioids crisis

The Honourable Ginette Petitpas Taylor, federal Minister of Health, will participate in training delivered by St. John Ambulance (BC and Yukon) and announce federal funding to address the opioid overdose crisis.

July 17, 2019
·
1 min read
Biotech Bay

Penumbra, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference

Penumbra, Inc. announced that its management team is scheduled to present at the Canaccord Genuity 39th Annual Growth Conference in Boston, MA on Wednesday, August 7, 2019.

July 17, 2019
·
1 min read
Deals

Mirum Pharmaceuticals Announces Pricing of Initial Public Offering

Mirum Pharmaceuticals, Inc., a clinical-stage therapeutics company developing a novel approach for treating cholestatic liver diseases, announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price to the public of $15.00 per share.

July 17, 2019
·
2 min read
Genetown

New Harvard Medical School Study Finds Blue Cross Blue Shield of Massachusetts Alternative Quality Contract Slowed Spending, Improved Care Over 8 Years

Blue Cross Blue Shield of Massachusetts’ Alternative Quality Contract slowed the rate of medical spending growth by up to 12% while improving patient care over the course of eight years, Harvard Medical School researchers report in a landmark study published in the New England Journal of Medicine.

July 17, 2019
·
4 min read
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute

QuickFire Challenge seeks to identify and accelerate game-changing, early-stage health tech innovations from around the world.

July 17, 2019
·
8 min read
Policy

Court Upholds The Validity And Determined Actavis’ Infringement Of Patent Protecting RELISTOR® Tablets

Bausch Health Companies Inc. and Progenics Pharmaceuticals, announced that the U.S. District Court of New Jersey upheld the validity and determined Actavis’ infringement of a patent protecting RELISTOR® tablets, expiring March 2031.

July 17, 2019
·
3 min read